Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: A cohort study of 11,575 patients with coronary artery disease

Journal of the American College of Cardiology

Volumn 33, Issue 7, 1999, Pages 1920-1925

  Leor, Jonathan ^b   Reicher Reiss, Henrietta ^b   Goldbourt, Uri ^b   Boyko, Valentina ^b   Gottlieb, Shmuel ^b   Battler, Alexander ^a   Behar, Solomon ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LISINOPRIL;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CAPTOPRIL; CORONARY DISEASE; CROSS-OVER STUDIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; ISRAEL; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 0032739790     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00129-1     Document Type: Article

References (25)

1. Hennekens C.H., Dyken M.L., Fuster V. Aspirin as a therapeutic agent in cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation. 96:1997;2751-2753.
2. Collaborative overview of randomized trials of antiplatelet therapy - I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 308:1994;81-106.
3. Patten R.D., Udelson J.E., Konstam M.A. Ventricular remodeling and its prevention in the treatment of heart failure. Curr Opin Cardiol. 13:1998;162-167.
4. Latini R., Maggioni A.P., Flather M., Sleight P., Tognoni G. ACE inhibitor use in patients with myocardial infarction summary of evidence from clinical trials . Circulation. 92:1995;3132-3137.
5. Cleland J.G.F., Bulpitt C.J., Falk R.H., et al. Is aspirin safe for patients with heart failure? Br Heart J. 74:1995;215-219.
6. Al-Khadra A.S., Salem D.N., Rand W.M., Udelson J.E., Smith J.J., Konstam M.A. Antiplatelet agents and survival a cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial . J Am Coll Cardiol. 31:1998;419-425.
7. Nguyen K.N., Aursnes I., Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (Consensus II) . Am J Cardiol. 79:1997;115-119.
8. Peterson J.G., Laur M.S., Young J.B., Sapp S., Califf R.M., Topol E.J. Evidence for an adverse interaction between ACE inhibitors and aspirin following myocardial infarction the GUSTO-I Trial . (abstr) J Am Coll Cardiol. 31:(Suppl A):1998;96A.
9. Hall D., Zeitler H., Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol. 20:1992;1549-1555.
10. Guazzi M., Giancarlo M., Alimento M., Contini M., Agostoni P. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation. 95:1997;1930-1936.
11. Guazzi M.D., Campodonico J., Celeste F., et al. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther. 63:1998;79-86.
12. Boger R.H., Bodeboger S.M., Kramme P., Tsikas D., Gutzki F.M., Frolich J.C. Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects interaction with low dose acetylsalicylic acid . Br J Clin Pharmacol. 42:1996;721-727.
13. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins kallikerins, kininogens, and kinases . Pharmacol Rev. 44:1992;1-80.
14. Moor T.J., Grantz F.R., Hollenberg N.K., et al. Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension. 3:1981;168-173.
15. Goldbourt U., Behar S., Reicher-Reiss H., et al. Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial). Am J Cardiol. 71:1993;909-915.
16. Braun S., Boyko V., Behar S., et al. Calcium antagonists and mortality in patients with coronary artery disease a cohort study of 11,575 patients . J Am Coll Cardiol. 28:1996;7-11.
17. Cox D.R. Regression methods of life table. J R Stat Soc. B34:1972;187-220.
18. Spaulding C., Charbonnier B., Cohen-Solal A., et al. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril results of a double-blind, randomized comparative trial . Circulation. 98:1998;757-765.
19. Dzau V.J., Packer M., Lilly L.S., Swartz S.L., Hollenberg N.K., Williams G.H. Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponathremia. N Engl J Med. 310:1984;347-352.
20. Baur L.H.B., Schipperheyn J.J., van der Laarse A., et al. Combining salicylate and enalapril in patients with coronary artery disease and heart failure. Br Heart J. 73:1995;227-236.
21. Effect of the ACE inhibitor lisonopril on mortality in diabetic patients with acute myocardial infarction. Data from the GISSI-3. Circulation. 96:1997;4239-4245.
22. Jeserich M., Pape L., Just H., et al. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure. Am J Cardiol. 76:1995;1079-1082.
23. Oosterga M., Anthonio R.L., de Kam P.J., Kingma J.H., Crijns H.J., van Gilst W.H. Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction. Am J Cardiol. 81:1998;1178-1181.
24. Alhaddad I.A., Tkaczevski L., Siddiqui F., Mir R., Brown E.J. Jr. Aspirin enhances the benefit of late reperfusion on infarct shape. A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction. Circulation. 91:1995;2819-2823.
25. Goldbourt U. Evaluating the association between drug use and outcome - should the information from observational studies affect therapeutic use. Cardiology. 88:(Suppl 3):1997;63-67.